SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce Rosen who wrote (3176)3/30/1998 8:50:00 AM
From: Hank  Read Replies (2) of 7041
 
Bruce,

You clearly have absolutely no clue as to what you're talking about or how things are done in the pharmaceutical industry. Pfizer could not claim a 70% efficacy for Viagra unless the clinical data supported this conclusion. The FDA wouldn't allow it. This is not supposition. It is a fact. I have seen no claims by either ZONA or SGP that the efficacy of Vasomax is expected to even approach these levels. IF SGP or ZONA really believed that it does, they would make it clear and be hyping the product a hell of a lot more than they are. If there is anyone that is unable to allow for the possibility of being wrong, it is you. You seem to believe that the people at SGP are gods and are incapable of screwing up. You seem to believe that ZONA was 100% truthful in providing SGP and others with accurate clinical data during the early stages of negotiation. I think it's real humorous that you feel you have the both experience and the right to tell me what is right and what is wrong with respect to Vasomax. I suggest you go get a PhD and spend 10 years in the industry like I have before you get on your soap box and tell me I am wrong. You have NOTHING of substance to say about this issue and you have ZERO credibility IMHO.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News